Published on: April 29, 2020
The US Food and Drug Administration (FDA) approved a new type of therapy for triple-negative breast cancer that has spread to other parts of the body and hasn’t responded to other treatments.
Published on: January 23, 2020
Taking certain supplements while undergoing chemotherapy for breast cancer may do more harm than good. A small study found that patients who took antioxidants had higher chances of cancer recurrence and death.
Published on: May 29, 2019
The US Food and Drug Administration (FDA) has approved the first treatment of its kind for a certain type of breast cancer caused by an inherited genetic mutation. Piqray (alpelisib) is a targeted therapy called a PI3K inhibitor.